most citedBenchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images

1 citations · 1 across the 1 of their papers we have counts for

collaborators

1 paper

eess.IV2024★ 1 cited

Benchmarking Histopathology Foundation Models for Ovarian Cancer Bevacizumab Treatment Response Prediction from Whole Slide Images

Mayur Mallya, Ali Khajegili Mirabadi, Hossein Farahani +1

Bevacizumab is a widely studied targeted therapeutic drug used in conjunction with standard chemotherapy for the treatment of recurrent ovarian cancer. While its administration has…